Cybin Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

281.70M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	-	-	-
Mar 31, 2024	-	-	-
Mar 31, 2023	-	-	-
Mar 31, 2022	-	-	-
Mar 31, 2021	686.88K	-	-
Mar 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Compugen	72.76M
C4 Therapeutics	35.95M
Orchestra BioMed Holdings	33.48M
Alector	21.05M
Adagene	7.67M
Milestone Pharmaceuticals	1.55M
SAB Biotherapeutics	114.70K

Revenue Rankings

HELP News

4 hours ago - Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions - GlobeNewsWire
4 hours ago - Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer - GlobeNewsWire
6 hours ago - Psychedelic drug makers rally as Trump orders FDA to expedite reviews - Reuters
4 days ago - Helus Pharma Strengthens Medical Leadership by Appointing Dr. Ken Kramer as Senior Vice President, Medical Affairs - GlobeNewsWire
5 weeks ago - Helus Pharma Strengthens Executive Team with Appointment of Jill Conwell as Chief People Officer - GlobeNewsWire
6 weeks ago - Helus Pharma Stock Tumbles As Anxiety Drug Study Disappoints - Benzinga
6 weeks ago - Helus Pharma Announces Topline Results in Phase 2 Signal Detection Study for HLP004 in Patients with Generalized Anxiety Disorder - GlobeNewsWire
7 weeks ago - Helus Pharma Appoints Former Pfizer Chief Medical Officer Dr. Freda Lewis-Hall to Board of Directors & Chair of the Scientific Advisory Committee - GlobeNewsWire

More News